E-28 | Outcomes of Transcatheter Aortic Valve Replacement in Asthma

Junaid Mir, Majd Al-Ahmad, Mohammad Aldiabat, Ali Akram, Musaab Alfaki, Mohammad Al Bataineh, Mubarra Nasir, Muhammad Shafique, M Chadi AlraiesJournal of the Society for Cardiovascular Angiography & Interventions 2024 · DOI

Abstract

Asthma is a worldwide problem with around 300 million people suffering from it and contributes to one out of every 250 deaths. Outcomes after TAVR in patients with asthma are unknown. We queried the National Inpatient Sample of the years 2016 to 2020. We identified patients who were admitted for TAVR procedure using ICD10 PCS codes. The risk of mortality and in-hospital complications in the asthma group was compared to the non-asthma group using multivariate logistic regression analysis. During 2016-2020, there were a total of 297,545 patients who were admitted for TAVR in the US of which 15,450(5.2%) had asthma, 282,095(94.8%) had an absence of asthma. 180(1.1%) patients died in hospital in the asthma group compared with 3885 patients (1.4%) in the non-asthma group. Mean Length of Stay (LOS) was 3.77 days vs 3.88days, while mean total cost of care was 208510$ in asthma group vs 217445$ in non-asthma group. After adjusting for demographics, smoking status, COPD, dependence on long term oxygen, history of lung transplant and OSA, there were lower odds of MI(aOR (adjusted odds ratio) 0.6; 95% CI 0.45–0.79 p<0.001) and cerebral infarction(aOR (adjusted odds ratio) 0.62; 95% CI 0.46–0.82 p=0.001) in asthma group compared to non-asthma group however there was no difference in odds of in-hospital mortality, GI bleeding, and pneumothorax between the two groups. Mean total cost of care and LOS in asthma group was lower compared to the other group. (Table 1) TAVR has lower odds of MI, cerebral infarction, decreased LOS, and mean total cost of care in asthma group. Observational studies and RTCs are needed to elucidate it further.
BibTeX
@article{mir2024e,
  author = {Junaid Mir and Majd Al-Ahmad and Mohammad Aldiabat and Ali Akram and Musaab Alfaki and Mohammad Al Bataineh and Mubarra Nasir and Muhammad Shafique and M Chadi Alraies},
  title = {{E-28 | Outcomes of Transcatheter Aortic Valve Replacement in Asthma}},
  journal = {Journal of the Society for Cardiovascular Angiography \& Interventions},
  year = {2024},
  doi = {10.1016/j.jscai.2024.101784},
}

Loading related content...

Figure